Cornercap Investment Counsel Inc Incyte Corp Transaction History

Cornercap Investment Counsel Inc

  • $329 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024
SELL
$51.18 - $63.75 $11,617 - $14,471
-227 Reduced 0.79%
28,512 $1.73 Million
Q1 2024

May 10, 2024
BUY
$56.55 - $66.59 $729,099 - $858,544
12,893 Added 81.36%
28,739 $1.64 Million
Q4 2023

Jan 30, 2024
BUY
$52.16 - $64.19 $826,527 - $1.02 Million
15,846 New
15,846 $994,000
Q3 2021

Nov 15, 2021
SELL
$68.67 - $84.02 $2.12 Million - $2.59 Million
-30,823 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$79.87 - $87.53 $2.46 Million - $2.7 Million
30,823 New
30,823 $2.59 Million

Others Institutions Holding INCY

# of Institutions
643
Shares Held
186M
Call Options Held
714K
Put Options Held
557K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Cornercap Investment Counsel Inc Portfolio

Follow Cornercap Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cornercap Investment Counsel Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email